Caracterização de corpúsculos e mediadores lipídicos em linhagens tumorais metastáticas e não metastáticas
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Lipid bodies (LB) are dynamic organelles that exert innumerable
functionalities, especially the regulation of lipid metabolism, being present in
normal cells and in cells associated with inflammatory processes. Breast cancer
is a disease that presents high incidence in the population; where the increase
of lipogenesis and cellular proliferative decontrol characterize the pathology.
Several studies correlated to tumor progression with the quantification of lipid
bodies, as well as the production of inflammatory mediators; Since in the
advanced stages of the disease a high number of LB are observed at the tumor
site, as well as the production of inflammatory mediators. Additionally, the
knowledge of the role of mTOR signaling pathway has been used to suggest
new therapies for cancer. Many studies aimed to elucidate the mechanisms that
promote homeostasis, as well as the understanding of the progression of breast
cancer, use two murine (4T1 and 67 NR), easily transplanted and tumorigenic
lines for the right purposes. The present work consists of characterizing the
production of inflammatory mediators and LB in two murine mammary tumor
cells, one with invasive capacity (4T1) and the other non-metastatic (67NR),
and in peritoneal macrophages treated with supernatant from 4T1 and 67NR
cells. Concomitantly, the role of the mTOR pathway modulation of lipid
metabolism was examined by treatment with rapamycin in the different cell
types. For this study tumor cells were cultured at time intervals 24 and 48h in
RPMI-1640 medium containing different concentrations of FBS (0 to 10%), pretreated or not with rapamycin. Our results demonstrated that the formation of LB
in the two strains is directly proportional to the concentration of SFB used and
the culture time. An increase in the production of leptin and TGF-β was
observed, with respective decrease of adiponectin by the two strains studied.
Additionally, we observed induction of LB and PGE2 synthesis in macrophages
treated with tumor cell supernatants. After the treatment with rapamycin there
was a inhibition of LB and increase of PGE2 when tumor cells and
macrophages were pretreated with rapamycin. Concomitant with some studies,
the participation of LB in tumor development is clear and its high quantification
is related to a worse prognosis of cancer due to the production of inflammatory
mediators. It should also be noted that the expressions of adiponectin and leptin
can be considered as a marker of cancer evaluation, which high levels of leptin
are seen in a worse prognosis in Breast Cancer.
Description
Keywords
Corpúsculo lipídico , Câncer de mama , 4T1 , 67NR , mTOR , Leptina , Lipid bodies , Breast cancer , 4T1 and 67NR , Leptin
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

